Biotech · Private company
Tessa Therapeutics
Track this companyFree. Adds Tessa Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials43 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- autologous EBV specific Cytotoxic T cellsPhase 3 · Nasopharyngeal CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- combination IV gemcitabine and IV carboplatin (AUC2)Phase 3 · Nasopharyngeal CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- BendamustinePhase 2 · Hodgkin Lymphoma, AdultClinicalTrials.gov · fetched Nov 12, 2026
- CD30.CAR-TPhase 2 · Hodgkin Lymphoma, AdultClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 2 · Hodgkin Lymphoma, AdultClinicalTrials.gov · fetched Nov 12, 2026
- Autologous CD30.CAR-TPhase 1 · Classical Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- BendamustinePhase 1 · Classical Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- CD30.CAR-TPhase 1 · Anaplastic Large Cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 1 · Classical Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 1 · Classical Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline TherapyPHASE1 · ACTIVE_NOT_RECRUITING · started Jul 25, 2022ClinicalTrials.gov NCT05352828 · fetched Nov 12, 2026
- Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin LymphomaPHASE1 · ACTIVE_NOT_RECRUITING · started Sep 8, 2021ClinicalTrials.gov NCT04526834 · fetched Nov 12, 2026
- Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 1, 2021ClinicalTrials.gov NCT04268706 · fetched Nov 12, 2026
- A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) PatientsPHASE3 · COMPLETED · started Jul 1, 2014ClinicalTrials.gov NCT02578641 · fetched Nov 12, 2026